A mutation in the gene KCTD1 leads to kidney defects that can ultimately cause metabolic bone disease.
Departments, Centers, & Programs:
50 Staniford Street
Boston, MA 02114-2517
- PhD, Harvard Medical School
- MD, University of Cologne School of Medicine
- Residency, New York Presbyterian Hospital
American Board Certifications
- Dermatology, American Board of Dermatology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Press Release
- Dec | 11 | 2020
New research by investigators at Massachusetts General Hospital (MGH) reveals insights into potential drivers of the disease — which currently has no cure — that could be targeted through prevention or treatment strategies. The findings are published in eLife.